A mutation hotspot at the p14ARF splice site

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Germline mutations in the CDKN2A gene are a known cause of hereditary melanoma.
• Mutations affecting the p16INK4a transcript are common, leading to the hypothesis that p14ARF plays a lesser role in melanoma predisposition.
• Exclusively identified mutations in p14ARF exon 1beta have been rare, primarily knockout mutations.

Purpose of the Study:

• To investigate the role of p14ARF exon 1beta in melanoma predisposition.
• To identify and characterize germline mutations within the p14ARF exon 1beta splice donor site in melanoma pedigrees.

Main Methods:

• Genetic analysis of melanoma pedigrees to identify germline mutations.
• Sanger sequencing to detect mutations in the p14ARF exon 1beta splice donor site.
• Analysis of mRNA splicing to confirm the functional impact of identified variants.

Main Results:

• A cluster of five distinct germline mutations at the p14ARF exon 1beta splice donor site was identified in melanoma pedigrees.
• All five identified splice site variants demonstrated evidence of being causal mutations.
• Three variants were confirmed to cause aberrant splicing of the p14ARF mRNA, directly implicating p14ARF in melanoma predisposition.

Conclusions:

• The p14ARF transcript of the CDKN2A gene plays a significant role in melanoma predisposition in a subset of affected families.
• The identification of splice site mutations affecting p14ARF exon 1beta expands the known spectrum of CDKN2A mutations in hereditary melanoma.
• Further research into the mutation spectrum of CDKN2A is warranted to fully elucidate the role of p14ARF in melanoma development.